volume 37 issue 3 pages 424-434

Demographic, clinical, laboratory data, prognostic, and treatment features of patients with antisynthetase syndrome: An international, two-center cohort study

Da Silva L.M., Rathore U., Agarwal V., Gupta L., Katsuyuki Shinjo S.
Publication typeJournal Article
Publication date2022-03-03
scimago Q3
wos Q4
SJR0.428
CiteScore2.1
Impact factor1.1
ISSN21485046, 26186500
Rheumatology
Abstract

Objectives: To compare clinical, demographic, laboratory data, prognostic and treatment characteristics of patients with antisynthetase syndrome (ASSD) treated in two different centers of India and Brazil.

Patients and methods: This international, two-center, retro-prospective cohort study which was conducted at two tertiary rheumatology centers (one in Brazil and one in India) between January 2000 to January 2020 included a total of 115 patients with ASSD (21 males, 94 females; mean age; at disease diagnosis at 40.3; range, 18 to 80 years). Demographic, clinical and laboratory data of the patients were recorded. Clinical involvement was evaluated.

Results: Of the patients, 81 were Brazilians and 34 were of Indian origin. The Indian group exhibited a greater delay in diagnosis after the onset of symptoms compared to Brazilian patients (12 vs. 6 months, respectively; p=0.026). Brazilian patients exhibited a significantly higher prevalence of joint and lung involvement, mechanic’s hands, and Raynaud’s phenomenon. Anti-Jo-1 was the most common autoantibodies in both groups. Systemic arterial hypertension, followed by diabetes mellitus were the most prevalent comorbidities. Concerning previously used drugs, the Indian patients had a larger group of patients treated with antimalarials, whereas the Brazilian group used more azathioprine and intravenous immunoglobulin. A higher proportion of Indian patients was treated with one immunosuppressive drug (70.6%), while the Brazilian group were often treated using two immunosuppressive drugs (33%). Comparison between the severity and prognosis showed that Brazilian group had a higher number of relapses, and during follow-up, the global mortality rates were similar in both groups (6.2% for Brazilian vs. 8.8% for Indian).

Conclusion: Brazilian and Indian patients with ASSD have comparable epidemiological characteristics such as age at the time of disease diagnosis, and sex distribution, and autoantibodies. Diagnostic delay is seen in Indian patients, and Brazilians exhibit a higher prevalence of joint and lung involvement, mechanic’s hands, Raynaud’s phenomenon with a higher number of relapses, although the mortality rate seems to be similar in both groups.

Found 
Found 

Top-30

Journals

1
Reumatismo
1 publication, 50%
Seminars in Respiratory and Critical Care Medicine
1 publication, 50%
1

Publishers

1
PAGEPress Publications
1 publication, 50%
Georg Thieme Verlag KG
1 publication, 50%
1
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
2
Share
Cite this
GOST |
Cite this
GOST Copy
Da S. et al. Demographic, clinical, laboratory data, prognostic, and treatment features of patients with antisynthetase syndrome: An international, two-center cohort study // Archives of Rheumatology. 2022. Vol. 37. No. 3. pp. 424-434.
GOST all authors (up to 50) Copy
Da S., Rathore U., Agarwal V., Gupta L., Katsuyuki S. Demographic, clinical, laboratory data, prognostic, and treatment features of patients with antisynthetase syndrome: An international, two-center cohort study // Archives of Rheumatology. 2022. Vol. 37. No. 3. pp. 424-434.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.46497/ArchRheumatol.2022.9108
UR - https://doi.org/10.46497/ArchRheumatol.2022.9108
TI - Demographic, clinical, laboratory data, prognostic, and treatment features of patients with antisynthetase syndrome: An international, two-center cohort study
T2 - Archives of Rheumatology
AU - Da, Silva
AU - Rathore, U
AU - Agarwal, V
AU - Gupta, L
AU - Katsuyuki, Shinjo
PY - 2022
DA - 2022/03/03
PB - Baycinar Medical Publishing
SP - 424-434
IS - 3
VL - 37
PMID - 36589603
SN - 2148-5046
SN - 2618-6500
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2022_Da,
author = {Silva Da and U Rathore and V Agarwal and L Gupta and Shinjo Katsuyuki},
title = {Demographic, clinical, laboratory data, prognostic, and treatment features of patients with antisynthetase syndrome: An international, two-center cohort study},
journal = {Archives of Rheumatology},
year = {2022},
volume = {37},
publisher = {Baycinar Medical Publishing},
month = {mar},
url = {https://doi.org/10.46497/ArchRheumatol.2022.9108},
number = {3},
pages = {424--434},
doi = {10.46497/ArchRheumatol.2022.9108}
}
MLA
Cite this
MLA Copy
Da, Silva, et al. “Demographic, clinical, laboratory data, prognostic, and treatment features of patients with antisynthetase syndrome: An international, two-center cohort study.” Archives of Rheumatology, vol. 37, no. 3, Mar. 2022, pp. 424-434. https://doi.org/10.46497/ArchRheumatol.2022.9108.